Malenka calls for MDMA research
In a Q&A, the neuroscientist discusses the reasons for continued basic and clinical research on an illegal drug scientists call 3,4-methylenedioxymethamphetamine, or MDMA, and partiers call Ecstasy.
Entwistle on taking the helm of SHC
In a Q&A, the new president and CEO of Stanford Health Care shares his thoughts about his new job and the evolving health care landscape.
Stafford: More plants, less meat
In a letter to JAMA, the preventive-medicine expert addresses the failure of the newest USDA Dietary Guidelines to articulate the health and climate benefits of a low-meat diet.
Owens on colorectal cancer screening
The health policy expert answered questions about the guidelines he co-authored that strongly recommend adults ages 50 to 75 be screened for colon cancer.
Swetter on choosing sunscreen
With summer just around the corner, a Stanford dermatologist discusses how to think about SPF labels, how to properly apply sunscreen, the differences between UVA and UVB radiation and more. what to consider when choosing a sunscreen and how to use it properly.
Desiree LaBeaud on the Zika virus
The infectious disease expert discusses the local risks of contracting the Zika virus, what precautions residents can take and what travelers outside the United States should do to avoid infection with the virus.
Hamad on neighborhoods and health
The Stanford researcher co-authored a new study showing that refugees assigned to the most deprived Swedish neighborhoods were 15 to 30 percent more likely to develop Type 2 diabetes.
Girod on gender bias in leadership
Sabine Girod led an effort to see if an educational intervention could reduce gender leadership bias among medical school faculty members. In short, it succeeded.
35 years ago: first successful heart-lung transplant
The surgeon who led the team that performed the first successful heart-lung transplant 35 years ago discusses his recollections of the patient and the operation.
Longo discusses dementia
In a recent interview, neurologist Frank Longo discussed Alzheimer’s disease, recent research breakthroughs and the new Stanford Neuroscience Health Center, which he co-leads.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.